Cargando...
Metformin Protects against Podocyte Injury in Diabetic Kidney Disease
Metformin is the most commonly prescribed drug for treating type 2 diabetes mellitus (T2D). Its mechanisms of action have been under extensive investigation, revealing that it has multiple cellular targets, either direct or indirect ones, via which it regulates numerous cellular pathways. Diabetic k...
Gardado en:
| Publicado en: | Pharmaceuticals (Basel) |
|---|---|
| Autor Principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
MDPI
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7764076/ https://ncbi.nlm.nih.gov/pubmed/33321755 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ph13120452 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|